Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-103791
Filing Date
2025-04-29
Accepted
2025-04-29 16:10:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d947735ddefa14a.htm DEFA14A 12289
2 GRAPHIC g947735g02g02.jpg GRAPHIC 232701
3 GRAPHIC g947735g03g03.jpg GRAPHIC 84845
  Complete submission text file 0001193125-25-103791.txt   441286
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39335 | Film No.: 25887644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)